Elanco Animal Health Inc

For the period ended Mar 31, 2025. Filed May 7, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 7, 2025

ELAN$26.76-0.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

CONDENSED CONSOLIDATED BALANCE SHEETS

(in millions, except share data)

	March 31, 2025	December 31, 2024
(Unaudited)
Assets
Current Assets
Cash and cash equivalents	$487	$468
Accounts receivable, net	970	805
Other receivables	90	81
Inventories	1,592	1,574
Prepaid expenses and other	301	287
Total current assets	3,440	3,215
Noncurrent Assets
Property and equipment, net	1,047	993
Goodwill	4,508	4,414
Other intangibles, net	3,634	3,681
Other noncurrent assets	312	311
Total assets	$12,941	$12,614
Liabilities and Equity
Current Liabilities
Accounts payable	$330	$296
Sales rebates and discounts	319	332
Current portion of long-term debt	44	44
Other current liabilities	576	643
Total current liabilities	1,269	1,315
Noncurrent Liabilities
Long-term debt	4,351	4,277
Deferred taxes	481	449
Other noncurrent liabilities	487	477
Total liabilities	6,588	6,518
Commitments and Contingencies
Equity
Common stock, no par value, 5,000,000,000 shares authorized, 496,458,420 and 494,445,839 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively	—	—
Additional paid-in capital	8,819	8,817
Accumulated deficit	(1,883)	(1,950)
Accumulated other comprehensive loss	(583)	(771)
Total equity	6,353	6,096
Total liabilities and equity	$12,941	$12,614

2025 Q1 Form 10-Q | 6

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.